Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle‐stimulated endothelial senescence and dysfunction: protective effect of gliflozins
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle‐stimulated endothelial senescence and dysfunction: protective effect of gliflozins
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-17
DOI
10.1186/s12933-021-01252-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat
- (2020) Sin-Hee Park et al. Cardiovascular Diabetology
- Empagliflozin prevents doxorubicin-induced myocardial dysfunction
- (2020) Jolanda Sabatino et al. Cardiovascular Diabetology
- Empagliflozin protects heart from inflammation and energy depletion via AMPK activation
- (2020) Chintan N. Koyani et al. PHARMACOLOGICAL RESEARCH
- Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
- (2020) Antonio Ceriello et al. Cardiovascular Diabetology
- Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction
- (2020) Rio P. Juni et al. KIDNEY INTERNATIONAL
- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
- (2019) Damilola D. Adingupu et al. Cardiovascular Diabetology
- Angiotensin II‐induced redox‐sensitive SGLT1 and 2 expression promotes high glucose‐induced endothelial cell senescence
- (2019) Sonia Khemais‐Benkhiat et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
- (2019) Domenico D’Amario et al. Frontiers in Physiology
- Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction
- (2018) Kathryn Dryer et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
- (2018) Sarayut Lahnwong et al. Cardiovascular Diabetology
- Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial
- (2018) Søren L. Kristensen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
- (2018) Silvio E. Inzucchi et al. CIRCULATION
- Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis
- (2018) Konstantinos Batzias et al. Journal of Diabetes Research
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and ThrombogenicityClinical Perspective
- (2016) Malak Abbas et al. CIRCULATION
- Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure
- (2016) Alexander E. Berezin et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells
- (2016) Masanori Wakisaka et al. PLoS One
- SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
- (2015) Silvio E Inzucchi et al. Diabetes & Vascular Disease Research
- Senescence-Induced Oxidative Stress Causes Endothelial Dysfunction
- (2015) Raj Bhayadia et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling
- (2015) Shyh-Jong Wu et al. PLoS One
- Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans
- (2015) Callie M Gustafson et al. Biology of Sex Differences
- Phosphatidylinositol 3-Kinase and Xanthine Oxidase Regulate Nitric Oxide and Reactive Oxygen Species Productions by Apoptotic Lymphocyte Microparticles in Endothelial Cells
- (2014) H. A. Mostefai et al. JOURNAL OF IMMUNOLOGY
- The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
- (2014) Matthias Oelze et al. PLoS One
- An Ethanolic Extract of Lindera obtusiloba Stems, YJP-14, Improves Endothelial Dysfunction, Metabolic Parameters and Physical Performance in Diabetic db/db Mice
- (2013) Jung-Ok Lee et al. PLoS One
- The PPARδ-mediated inhibition of angiotensin II-induced premature senescence in human endothelial cells is SIRT1-dependent
- (2012) Min Young Kim et al. BIOCHEMICAL PHARMACOLOGY
- Grape-Derived Polyphenols Improve Aging-Related Endothelial Dysfunction in Rat Mesenteric Artery: Role of Oxidative Stress and the Angiotensin System
- (2012) Noureddine Idris Khodja et al. PLoS One
- NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1
- (2011) Magali Balteau et al. CARDIOVASCULAR RESEARCH
- Circulating microparticle levels in patients with coronary artery disease: a new indicator of vulnerability?
- (2011) N. Amabile et al. EUROPEAN HEART JOURNAL
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- p53 Impairs Endothelial Function by Transcriptionally Repressing Kruppel-Like Factor 2
- (2010) Ajay Kumar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Microparticles
- (2010) Sebastian F. Mause et al. CIRCULATION RESEARCH
- Shear Stress Regulates Angiotensin Type 1 Receptor Expression in Endothelial Cells
- (2009) Bhama Ramkhelawon et al. CIRCULATION RESEARCH
- Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo
- (2009) Florence Debacq-Chainiaux et al. Nature Protocols
- Circulating Endothelial Microparticles Correlate Inversely With Endothelial Function in Patients With Ischemic Left Ventricular Dysfunction
- (2008) Daniel Bulut et al. JOURNAL OF CARDIAC FAILURE
- Endothelial Cell Activation Contributes to the Release of Procoagulant Microparticles During Acute Cardiac Allograft Rejection
- (2008) Olivier Morel et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Angiotensin II-Induced Hypertension Is Associated with a Selective Inhibition of Endothelium-Derived Hyperpolarizing Factor-Mediated Responses in the Rat Mesenteric Artery
- (2008) S. Dal-Ros et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started